Cart
sales@molnova.com
SM27
CAS No. 6266-54-2
SM27( —— )
Catalog No. M34029 CAS No. 6266-54-2
SM27 is a fibroblast growth factor 2 (FGF2) inhibitor with anti-angiogenic activity and can be used to study tumours.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSM27
-
NoteResearch use only, not for human use.
-
Brief DescriptionSM27 is a fibroblast growth factor 2 (FGF2) inhibitor with anti-angiogenic activity and can be used to study tumours.
-
DescriptionSM27 is a fibroblast growth factor 2 (FGF2) inhibitor with anti-angiogenic activity and can be used to study tumours.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFGFR
-
RecptorFGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6266-54-2
-
Formula Weight504.49
-
Molecular FormulaC21H16N2O9S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC=1C=CC2=CC(=CC(O)=C2C1)S(=O)(=O)O)NC=3C=CC4=CC(=CC(O)=C4C3)S(=O)(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Vofatamab
Vofatamab (B-701) is a fully human monoclonal antibody targeting FGFR3. Vofatamab has potential anticancer and antitumor activity and is often used in combination with other compounds to treat cancer.
-
ASP-5878
ASP5878 potently inhibited the tyrosine kinase activities of recombinant FGFR1 2 3 and 4 with IC50 values of 0.47 0.60 0.74 and 3.5 nmol/L.
-
BO-264
BO-264 is a highly potent and orally active inhibitor of transforming acidic coiled-coil 3 (TACC3, IC50 of 188 nM and a Kd of 1.5 nM).
